COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 541: Articles 5401-5410  | Next

CASCADIA: A prospective community-based study protocol for assessing SARS-CoV-2 vaccine effectiveness in children and adults utilizing a remote nasal swab collection and web-based survey design
Babu, T. M., Feldstein, L. R., Saydah, S., Acker, Z., Boisvert, C. L., Briggs-Hagen, M., Carone, M., Casto, A., Cox, S. N., Ehmen, B., Englund, J. A., Fortmann, S. P., Frivold, C. J., Groom, H., Han, P., Kuntz, J. L., Lockwood, T., Midgley, C. M., Mularski, R. A., Ogilvie, T., Reich, S., Schmidt, M. A., Smith, N., Starita, L., Stone, J., Vandermeer, M., Weil, A., Wolf, C. R., Chu, H. Y., Naleway, A. L.
10.1101/2023.01.05.22283913 — Posted: 2023-01-07
Counting Cases and Deaths by Age Tells Us About COVID-19 Infectious and Lethal Components
Michaelson, J. S.
10.1101/2023.01.05.23284239 — Posted: 2023-01-07
Nursing Intervention Analysis in COVID-19 Negative Pressure Isolation Wards and General Wards: Observational study
Kim, H. H., Park, H., Lee, M. s., Lee, G. M., Oh, H., Hwangbo, S., Roh, S.
10.1101/2023.01.06.23284223 — Posted: 2023-01-07
Oral Azvudine (FNC) Tablets in Patients infected with SARS-CoV-2 Omicron Variant: A Retrospective Cohort Study
Chen, W., Xu, H., Hong, L., Yang, R., Peng, C., Wang, G., Li, W.
10.1101/2023.01.05.23284180 — Posted: 2023-01-06
Omicron Spike Protein Is Vulnerable to Reduction
Stagljar, I., Yao, Z., Geng, B., Marcon, E., Pu, S., Tang, H., Merluza, J., Bello, A., Snider, J., Lu, P., Wood, H.
10.1101/2023.01.06.522977 — Posted: 2023-01-06
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides
Llewellyn, G. N., Chen, H.-Y., Rogers, G. L., Huang, X., Sell, P., Henley, J. E., Cannon, P. M.
10.1101/2023.01.05.522964 — Posted: 2023-01-06
Direct comparison of clinical diagnostic sensitivity of saliva from buccal swabs versus combined oro-/nasopharyngeal swabs in the detection of SARS-CoV-2 B.1.1.529 Omicron
Puyskens, A., Michel, J., Stoliaroff-Pepin, A., Bayram, F., Sesver, A., Wichmann, O., Harder, T., Schaade, L., Nitsche, A., Peine, C.
10.1101/2023.01.05.23284222 — Posted: 2023-01-06
Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected with Omicron subvariants and XBB recombinant variant
Karyakarte, R., Das, R., Dudhate, S., Agarasen, J., Pillai, P., Chandankhede, P., Labhshetwar, R., Gadiyal, Y., Rajmane, M., Kulkarni, P., Nizarudeen, S., Joshi, S., Potdar, V., Karmodiya, K.
10.1101/2023.01.05.23284211 — Posted: 2023-01-06
Cost & Cost-Effectiveness of Implementing SD Biosensor Antigen Detecting SARs-CoV-2 Rapid Diagnostic Tests in Kenya
Arwah, B., Mbugua, S., Ngure, J., Makau, M., Mwaura, P., Kamau, D., Nshimirimana, D. A., Barasa, E., Gitaka, J.
10.1101/2023.01.05.23284225 — Posted: 2023-01-05
Ethnic differences in the indirect impacts of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: An observational cohort study using OpenSAFELY
Costello, R. E., Tazare, J., Piehlmaier, D., Herrett, E., Parker, E. P., Zheng, B., Mansfield, K. E., Henderson, A. D., Carreira, H., Bidulka, P., Wong, A. Y., Warren-Gash, C., Hayes, J. F., Quint, J. K., MacKenna, B., Eggo, R. M., Katikireddi, S. V., Tomlinson, L., Langan, S. M., Mathur, R., The longitudinal health and wellbeing, , The OpenSAFELYcollaborative
10.1101/2023.01.04.23284174 — Posted: 2023-01-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).